{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T04:44:48Z","timestamp":1791521088668,"version":"4.3.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T00:00:00Z","timestamp":1730073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T00:00:00Z","timestamp":1730073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"High Level-Hospital Program, Health Commission of Guangdong Province","award":["HKUSZH201906001"],"award-info":[{"award-number":["HKUSZH201906001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-73408-6","type":"journal-article","created":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T09:20:06Z","timestamp":1730107206000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A large-scale retrospective study in China explores risk factors for disease severity in plaque psoriasis"],"prefix":"10.1038","volume":"14","clinical-trial-number":[{"clinical-trial-number":"chictr1900024852","registry":"10.18810\/chictr"}],"author":[{"given":"Huiwei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialiang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suchun","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongzhong","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuling","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuqiu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingjun","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youkun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5842-8080","authenticated-orcid":false,"given":"Gang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0867-8864","authenticated-orcid":false,"given":"Xiaoming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,28]]},"reference":[{"key":"73408_CR1","doi-asserted-by":"publisher","first-page":"740968","DOI":"10.3389\/fimmu.2021.740968","volume":"12","author":"P Liu","year":"2021","unstructured":"Liu, P. et al. Predicting the risk of psoriatic arthritis in plaque psoriasis patients: Development and assessment of a new predictive nomogram. Front. Immunol. 12, 740968 (2021).","journal-title":"Front. Immunol."},{"issue":"3","key":"73408_CR2","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1093\/bjd\/ljac086","volume":"188","author":"NAL Rosen\u00f8","year":"2023","unstructured":"Rosen\u00f8, N. A. L. et al. Exploring disease comorbidities and temporal disease progression of psoriasis: An observational, retrospective, multi-database, cohort study. Br. J. Dermatol. 188(3), 372\u2013379 (2023).","journal-title":"Br. J. Dermatol."},{"issue":"9","key":"73408_CR3","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/s41584-022-00810-7","volume":"18","author":"S Tarannum","year":"2022","unstructured":"Tarannum, S. et al. Sex- and gender-related differences in psoriatic arthritis. Nat. Rev. Rheumatol. 18(9), 513\u2013526 (2022).","journal-title":"Nat. Rev. Rheumatol."},{"issue":"4","key":"73408_CR4","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1111\/bjd.18245","volume":"182","author":"NJ Korman","year":"2020","unstructured":"Korman, N. J. Management of psoriasis as a systemic disease: What is the evidence? Br. J. Dermatol. 182(4), 840\u2013848 (2020).","journal-title":"Br. J. Dermatol."},{"issue":"9583","key":"73408_CR5","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/S0140-6736(07)61129-5","volume":"370","author":"A Menter","year":"2007","unstructured":"Menter, A. & Griffiths, C. E. Current and future management of psoriasis. Lancet (London England). 370(9583), 272\u2013284 (2007).","journal-title":"Lancet (London England)"},{"issue":"5","key":"73408_CR6","first-page":"D11535","volume":"4","author":"E Sbidian","year":"2021","unstructured":"Sbidian, E. et al. Systemic pharmacological treatments for chronic plaque psoriasis: A network meta-analysis. Cochrane Database Syst. Rev. 5(5),\u00a0CD011535\u00a0(2022).","journal-title":"Cochrane Database Syst. Rev."},{"issue":"2","key":"73408_CR7","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/jdv.16926","volume":"35","author":"A Nast","year":"2021","unstructured":"Nast, A. et al. EuroGuiDerm Guideline on the systemic treatment of psoriasis vulgaris - part 2: Specific clinical and comorbid situations. J. Eur. Acad. Dermatol. Venereol. 35(2), 281\u2013317 (2021).","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"73408_CR8","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jaad.2019.08.026","volume":"82","author":"B Strober","year":"2020","unstructured":"Strober, B. et al. Recategorization of psoriasis severity: Delphi consensus from the International Psoriasis Council. J. Am. Acad. Dermatol. 82(1), 117\u2013122 (2020).","journal-title":"J. Am. Acad. Dermatol."},{"key":"73408_CR9","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1111\/bjd.21023","volume":"186","author":"K Geale","year":"2022","unstructured":"Geale, K. & Schmitt-Egenolf, M. Severity of psoriasis: Time to disentangle severity from symptom control. Br. J. Dermatol. 186(6), 1033\u20131034 (2022).","journal-title":"Br. J. Dermatol."},{"key":"73408_CR10","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1111\/j.1365-2133.2005.06502.x","volume":"152","author":"AY Finlay","year":"2005","unstructured":"Finlay, A. Y. Current severe psoriasis and the rule of tens. Br. J. Dermatol. 152(5), 861\u2013867 (2005).","journal-title":"Br. J. Dermatol."},{"key":"73408_CR11","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1007\/s13555-022-00758-2","volume":"12","author":"K Peris","year":"2022","unstructured":"Peris, K. et al. Update on the management of pediatric psoriasis: An Italian Consensus. Dermatol. Ther. (Heidelb). 12(6), 1753\u20131775 (2022).","journal-title":"Dermatol. Ther. (Heidelb)"},{"key":"73408_CR12","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/jdv.12106","volume":"28","author":"PL Mattei","year":"2014","unstructured":"Mattei, P. L., Corey, K. C. & Kimball, A. B. Psoriasis area severity index (PASI) and the dermatology life quality index (DLQI): The correlation between disease severity and psychological burden in patients treated with biological therapies. J. Eur. Acad. Dermatol. Venereol. 28(4), 333\u2013337 (2014).","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"73408_CR13","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1111\/jdv.18913","volume":"37","author":"L Gargiulo","year":"2023","unstructured":"Gargiulo, L. et al. Real-life effectiveness and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: A 104-week multicenter retrospective study - IL PSO (ITALIAN LANDSCAPE PSORIASIS). J. Eur. Acad. Dermatol. Venereol. 37(5), 1017\u20131027 (2023).","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"73408_CR14","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1002\/bjs.10242","volume":"103","author":"J Ranstam","year":"2016","unstructured":"Ranstam, J., Cook, J. A. & Collins, G. S. Clinical prediction models. Br. J. Surg. 103(13), 1886 (2016).","journal-title":"Br. J. Surg."},{"key":"73408_CR15","doi-asserted-by":"publisher","first-page":"g7594","DOI":"10.1136\/bmj.g7594","volume":"350","author":"GS Collins","year":"2015","unstructured":"Collins, G. S. et al. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): The TRIPOD statement. BMJ. 350, g7594 (2015).","journal-title":"BMJ"},{"key":"73408_CR16","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jaad.2020.04.139","volume":"84","author":"S Mehrmal","year":"2021","unstructured":"Mehrmal, S. et al. The global, regional, and national burden of psoriasis in 195 countries and territories, 1990 to 2017: A systematic analysis from the global burden of Disease Study 2017. J. Am. Acad. Dermatol. 84(1), 46\u201352 (2021).","journal-title":"J. Am. Acad. Dermatol."},{"key":"73408_CR17","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.jaad.2021.03.020","volume":"86","author":"Z Nazir","year":"2022","unstructured":"Nazir, Z., Strunk, A. & Garg, A. Age- and sex-adjusted prevalence estimates among adults with psoriasis in the United States. J. Am. Acad. Dermatol. 86(3), 703\u2013705 (2022).","journal-title":"J. Am. Acad. Dermatol."},{"key":"73408_CR18","doi-asserted-by":"publisher","first-page":"e112","DOI":"10.1097\/JW9.0000000000000112","volume":"9","author":"A Gonzalez-Cantero","year":"2023","unstructured":"Gonzalez-Cantero, A. et al. Gender perspective in psoriasis: A scoping review and proposal of strategies for improved clinical practice by European dermatologists. Int. J. Womens Dermatol. 9(4), e112. https:\/\/doi.org\/10.1097\/JW9.0000000000000112 (2023).","journal-title":"Int. J. Womens Dermatol."},{"key":"73408_CR19","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.1097\/JW9.0000000000000010","volume":"8","author":"C Guillet","year":"2022","unstructured":"Guillet, C. et al. The impact of gender and sex in psoriasis: What to be aware of when treating women with psoriasis. Int. J. Womens Dermatol. 8(2), e10. https:\/\/doi.org\/10.1097\/JW9.0000000000000010 (2022).","journal-title":"Int. J. Womens Dermatol."},{"key":"73408_CR20","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1002\/art.41741","volume":"73","author":"P Karmacharya","year":"2021","unstructured":"Karmacharya, P. et al. The epidemiology of psoriatic arthritis over five decades: A population-based study. Arthritis Rheumatol. 73(10), 1878\u20131885 (2021).","journal-title":"Arthritis Rheumatol."},{"key":"73408_CR21","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s40257-017-0274-0","volume":"18","author":"D H\u00e4gg","year":"2017","unstructured":"H\u00e4gg, D. et al. Severity of psoriasis differs between men and women: A study of the clinical outcome measure psoriasis area and severity index (PASI) in 5438 Swedish register patients. Am. J. Clin. Dermatol. 18(4), 583\u2013590 (2017).","journal-title":"Am. J. Clin. Dermatol."},{"key":"73408_CR22","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.3389\/fphar.2019.01497","volume":"10","author":"S D\u2019Angelo","year":"2019","unstructured":"D\u2019Angelo, S. et al. Effectiveness of adalimumab for the treatment of psoriatic arthritis: An Italian real-life retrospective study. Front. Pharmacol. 10, 1497 (2019).","journal-title":"Front. Pharmacol."},{"key":"73408_CR23","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.semarthrit.2019.07.003","volume":"50","author":"B Michelsen","year":"2020","unstructured":"Michelsen, B. et al. Four-year follow-up of inflammatory arthropathy patients treated with golimumab: Data from the observational multicentre NOR-DMARD study. Semin Arthritis Rheum. 50(1), 12\u201316 (2020).","journal-title":"Semin Arthritis Rheum."},{"key":"73408_CR24","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s40744-021-00286-z","volume":"8","author":"P Sewerin","year":"2021","unstructured":"Sewerin, P. et al. Real-world treatment persistence with biologic disease-modifying antirheumatic drugs among German patients with psoriatic Arthritis-A retrospective database study. Rheumatol. Ther. 8(1), 483\u2013497 (2021).","journal-title":"Rheumatol. Ther."},{"key":"73408_CR25","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1007\/s10067-020-05027-1","volume":"39","author":"L Navarini","year":"2020","unstructured":"Navarini, L. et al. Retention rates and identification of factors associated with anti-TNF\u03b1, anti-IL17, and anti-IL12\/23R agents discontinuation in psoriatic arthritis patients: Results from a real-world clinical setting. Clin. Rheumatol. 39(9), 2663\u20132670 (2020).","journal-title":"Clin. Rheumatol."},{"key":"73408_CR26","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1093\/rheumatology\/kex387","volume":"7","author":"C Stober","year":"2018","unstructured":"Stober, C. et al. Prevalence and predictors of tumour necrosis factor inhibitor persistence in psoriatic arthritis. Rheumatol. (Oxford). 7(1), 158\u2013163 (2018).","journal-title":"Rheumatol. (Oxford)"},{"key":"73408_CR27","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1159\/000455840","volume":"232","author":"P Jensen","year":"2016","unstructured":"Jensen, P. & Skov, L. Psoriasis and obesity. Dermatology. 232(6), 633\u2013639 (2016).","journal-title":"Dermatology"},{"key":"73408_CR28","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s40257-016-0211-7","volume":"17","author":"P Gisondi","year":"2016","unstructured":"Gisondi, P., Del Giglio, M. & Girolomoni, G. Considerations for systemic treatment of psoriasis in obese patients. Am. J. Clin. Dermatol. 17(6), 609\u2013615 (2016).","journal-title":"Am. J. Clin. Dermatol."},{"key":"73408_CR29","doi-asserted-by":"publisher","first-page":"7396","DOI":"10.3390\/ijms23137396","volume":"23","author":"A Kisielnicka","year":"2022","unstructured":"Kisielnicka, A. et al. The analysis of a genome-wide association study (GWAS) of overweight and obesity in Psoriasis. Int. J. Mol. Sci. 23(13), 7396 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"73408_CR30","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1517\/14712598.2014.900541","volume":"14","author":"N Al-Mutairi","year":"2014","unstructured":"Al-Mutairi, N. & Nour, T. The effect of weight reduction on treatment outcomes in obese patients with psoriasis on biologic therapy: A randomized controlled prospective trial. Expert Opin. Biol. Ther. 14(6), 749\u2013756 (2014).","journal-title":"Expert Opin. Biol. Ther."},{"key":"73408_CR31","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.3945\/ajcn.2008.26427","volume":"88","author":"P Gisondi","year":"2008","unstructured":"Gisondi, P. et al. Weight loss improves the response of obese patients with moderate-to-severe chronic plaque psoriasis to low-dose cyclosporine therapy: A randomized, controlled, investigator-blinded clinical trial. Am. J. Clin. Nutr. 88(5), 1242\u20131247 (2008).","journal-title":"Am. J. Clin. Nutr."},{"key":"73408_CR32","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.jaad.2020.07.087","volume":"84","author":"CA Elmets","year":"2021","unstructured":"Elmets, C. A. et al. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures. J. Am. Acad. Dermatol. 84(2), 432\u2013470 (2021).","journal-title":"J. Am. Acad. Dermatol."},{"key":"73408_CR33","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/s41586-022-04536-0","volume":"604","author":"SP Bapat","year":"2022","unstructured":"Bapat, S. P. et al. Obesity alters pathology and treatment response in inflammatory disease. Nature. 604(7905), 337\u2013342 (2022).","journal-title":"Nature"},{"key":"73408_CR34","doi-asserted-by":"publisher","first-page":"711060","DOI":"10.3389\/fimmu.2021.711060","volume":"12","author":"Y Hao","year":"2021","unstructured":"Hao, Y. et al. Metabolic syndrome and psoriasis: Mechanisms and future directions. Front. Immunol. 12, 711060 (2021).","journal-title":"Front. Immunol."},{"key":"73408_CR35","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.jaad.2022.11.010","volume":"88","author":"CV Chalitsios","year":"2023","unstructured":"Chalitsios, C. V. et al. Investigating modifiable pathways in psoriasis: A mendelian randomization study. J. Am. Acad. Dermatol. 88(3), 593\u2013601 (2023).","journal-title":"J. Am. Acad. Dermatol."},{"key":"73408_CR36","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1111\/bjd.16116","volume":"178","author":"I Snast","year":"2018","unstructured":"Snast, I. et al. Psychological stress and psoriasis: A systematic review and meta-analysis. Br. J. Dermatol. 178(5), 1044\u20131055 (2018).","journal-title":"Br. J. Dermatol."},{"key":"73408_CR37","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.jcmg.2018.08.038","volume":"13","author":"A Goyal","year":"2020","unstructured":"Goyal, A. et al. Chronic stress-related neural activity associates with subclinical cardiovascular disease in psoriasis: A prospective cohort study. JACC Cardiovasc. Imaging. 13(2 Pt 1), 465\u2013477 (2020).","journal-title":"JACC Cardiovasc. Imaging"},{"key":"73408_CR38","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1016\/j.cell.2023.05.001","volume":"186","author":"KM Schneider","year":"2023","unstructured":"Schneider, K. M. et al. The enteric nervous system relays psychological stress to intestinal inflammation. Cell. 186(13), 2823\u20132838.e20 (2023).","journal-title":"Cell"},{"key":"73408_CR39","doi-asserted-by":"publisher","first-page":"353","DOI":"10.2174\/0113894501292755240304063020","volume":"25","author":"B Soni","year":"2024","unstructured":"Soni, B. et al. An overview of contemporary and future therapeutic strategies for scalp psoriasis. Curr. Drug Targets. 25(5), 353\u2013373 (2024).","journal-title":"Curr. Drug Targets"},{"key":"73408_CR40","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.jaad.2008.11.890","volume":"60","author":"CS Chan","year":"2009","unstructured":"Chan, C. S. et al. J. Am. Acad. Dermatol. 60(6), 962\u2013971 (2009).","journal-title":"J. Am. Acad. Dermatol."},{"key":"73408_CR41","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s13555-021-00521-z","volume":"11","author":"M Mosca","year":"2021","unstructured":"Mosca, M. et al. Scalp psoriasis: A literature review of effective therapies and updated recommendations for practical management. Dermatol. Ther. (Heidelb). 11(3), 769\u2013797 (2021).","journal-title":"Dermatol. Ther. (Heidelb)"},{"key":"73408_CR42","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1111\/ijd.14492","volume":"58","author":"AN Passos","year":"2019","unstructured":"Passos, A. N., de R\u00eago, A. & Duarte, V. R. P. Facial involvement and the severity of psoriasis. Int. J. Dermatol. 58(11), 1300\u20131304 (2019).","journal-title":"Int. J. Dermatol."},{"key":"73408_CR43","doi-asserted-by":"publisher","first-page":"522","DOI":"10.4103\/ijdvl.IJDVL_655_18","volume":"87","author":"PSS Ranugha","year":"2021","unstructured":"Ranugha, P. S. S., Bishnoi, P. & Chandrashekar, L. Facial involvement in Indian psoriatic patients and its association with disease severity and metabolic syndrome: A cross-sectional study. Indian J. Dermatol. Venereol. Leprol. 87(4), 522\u2013527 (2021).","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"key":"73408_CR44","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s41572-021-00293-y","volume":"7","author":"O FitzGerald","year":"2021","unstructured":"FitzGerald, O. et al. Psoriatic arthritis. Nat. Rev. Dis. Primers. 7(1), 59 (2021).","journal-title":"Nat. Rev. Dis. Primers"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-73408-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-73408-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-73408-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T12:03:12Z","timestamp":1730376192000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-73408-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,28]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["73408"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-73408-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,28]]},"assertion":[{"value":"11 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The research that involved human participants underwent a review and approval process by The University of Hong Kong-Shenzhen Hospital, Guangzhou Shenzhen, China. Participants who took part in the study supplied written informed consent through their legal guardian or next of kin. Reviewed and approved by HKU-SZH Medical Ethics Committee [2019]181.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"This study does not involve the use of patient photographs or other identifiable material. All data used in this research are anonymized and do not disclose any personal or sensitive information.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"25749"}}